Skip to main content

Business

By Jessica Hagen | 12:33 pm | January 10, 2024
The funding will be used to support the company's expansion.
By Jessica Hagen | 01:39 pm | January 09, 2024
The funding marks the completion of the company's merger with Amelia Virtual Care, and the investment will be used to support the combined companies' growth.
By Jessica Hagen | 02:22 pm | January 05, 2024
Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.
By Jessica Hagen | 04:00 pm | January 04, 2024
The company's proprietary technology aims to reduce motion sickness in an extended reality environment by stimulating the inner ear's vestibular system.
By Jessica Hagen | 04:09 pm | January 03, 2024
The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.
By Jessica Hagen | 05:52 pm | January 02, 2024
The funds come two years after the company scored a $1.15 billion investment.
By Jessica Hagen | 02:13 pm | January 02, 2024
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.
By Jessica Hagen | 02:01 pm | December 28, 2023
The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.
By Jessica Hagen | 01:57 pm | December 27, 2023
President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.
By Jessica Hagen | 01:41 pm | December 26, 2023
Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.